Cord Blood America, Inc. (OTC:CBAI.ob), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, announced yesterday that Matthew Schissler, CEO and co-founder, explains in detail the plans for the Company’s recapitalization in a ten-minute interview. The video and text of the speech is given below.
Cord Blood America Plans for Recapitalization
Previous post: Cancer Innovators To Bid On
Next post: CBAI Invests in VIDAPLUS